Oncology nurse April Fowler, pictured with her husband and three daughters, shares her personal stage 4 cancer journey, reflecting on clinical empathy, patient advocacy, and oncology endurance. Photo ...

In this podcast, experts Benjamin P. Levy, MD; Laura Alder, MD; and Beth Sandy, MSN, CRNP, FAPO, discuss biomarker testing ...

FDA approves belzutifan with lenvatinib for advanced clear cell RCC after PD-1/PD-L1 inhibitor failure. Review LITESPARK-011 ...

Chasity Washington MPH, CHES | Authors | Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

FDA approves lirafugratinib (Lyrfigtu) for FGFR2+ cholangiocarcinoma. Review REFOCUS trial data, 70 mg daily dosing, and ...

The University of Kansas Cancer Center The University of South Alabama, Mitchell Cancer Institute The University of Texas MD Anderson Cancer Center The Winthrop P. Rockefeller Cancer Institute at the ...

Commercialized by Lantheus Holdings, Inc., lutetium lu 177 dotatate (previously designated as PNT2003) represents the first ...

From ICN 2026, Heather Jackson and Ashley Johnson detail APP breast care access models, global cancer pain barriers, and burnout mitigation tactics. At the International Council of Nurses and Nurse ...

The American Nurses Association (ANA) has released an updated position statement, "Addressing Nurse Fatigue to Promote Health, Safety, and Well-Being for All," reframing nurse fat ...

NCCN survey data show 100% of cancer centers face drug shortages, with ifosfamide and carboplatin critical. Survey findings ...

Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinical trials and nursing impacts of on-body isatuximab delivery in multiple myeloma. In the second episode of a special Oncology Nursing News ...